Indian Army Pertuzumab and Other Pharmaceuticals Tender Pune Maharashtra - Estimated Value ₹9,887,067.60 2025
Bid Publish Date
17-Oct-2025, 12:13 pm
Bid End Date
31-Oct-2025, 1:00 pm
Value
₹98,87,068
Location
Progress
RAQuantity
8887
Category
PERTUZUMAB VIAL OF 420 MG INJ
Bid Type
Two Packet Bid
Key Highlights
- • Minimum 5 years residual market life for products
- • Manufacturer authorization required for distributors
- • Experience supplying similar products to government organizations
- • Data sheet submission mandatory for product verification
- • Compliance with hazardous material regulations
- • Bid rejection for technical parameter mismatches
- • Contract termination rights for non-compliance
- • GST invoice upload required on GeM portal
Categories
6
Tender Overview
The Indian Army is procuring various pharmaceuticals including Pertuzumab Vial 420 mg, Alectinib 150 mg, and 5-Fluorouracil 500 mg injections in Pune, Maharashtra. The estimated value of this tender is ₹9,887,067.60. Bidders must ensure that the products offered have a minimum of 5 years residual market life and are not obsolete. This tender includes a total of 14 items for supply.
Technical Specifications & Requirements
Bidders must adhere to the following specifications:
- Product Life: Offered products must have at least 5 years residual market life.
- Documentation: Submit a Data Sheet for each product, along with:
- Copy of PAN Card
- Copy of GSTIN
- Copy of Cancelled Cheque
- EFT Mandate certified by the bank.
- Manufacturer Authorization: Required for authorized distributors, including OEM details.
- Hazardous Materials: Compliance with safety regulations during transportation and storage.
Terms, Conditions & Eligibility
Key eligibility criteria include:
- Experience: Bidders must have supplied similar products to any Central/State Government Organization or PSU for at least 3 years.
- Bid Rejection: Bids may be rejected for unexplained mismatches in technical parameters.
- Contract Termination: The buyer may terminate the contract for non-compliance with material terms or delivery failures.
- Invoice Requirements: Upload scanned copies of GST invoices on the GeM portal.
Key Specifications
-
Minimum 5 years residual market life for offered products
-
Data Sheet required for product verification
-
Manufacturer Authorization needed for distributors
Terms & Conditions
-
Experience supplying similar products for at least 3 years
-
Bid rejection for technical mismatches
-
Contract termination rights for delivery failures
Important Clauses
Documentation Requirements
Bidders must submit PAN, GSTIN, cancelled cheque, and EFT mandate.
Experience Criteria
Bidders must have 3 years of experience supplying similar products.
Contract Termination
Buyer can terminate the contract for non-compliance or delivery failures.
Bidder Eligibility
-
Must have supplied similar products to government organizations for 3 years
-
Products must have at least 5 years residual market life
-
Authorized distributors must provide manufacturer authorization
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
PERTUZUMAB VIAL OF 420 MG INJ , Alectinib 150 mg Tab , 5 Fluorouracil 500mg 10 ml Inj , TRANS DERMA PATCH BUPRENORPHINE EP 20 MG , AFATINIB 40 MG TAB , DOXORUBICIN HCL 2MG ML 5ML INJ , EPIRUBICIN HCL 10 MG INJ , EXEMESTANE 25 MG TAB , FENTANYL 25 MCG TRANSDERMAL , PACLITAXEL 100MG INJ , Lenvatinib 4 mg Tab Cap , ERLOTINIB 150 MG TAB , Trastuzumab Deruxtecan concentrate solution for infusion 100mg 5ml Vial Inj , Human papiloma 9 Valent recombinant Vaccine Type 6 11 16 18 31 33 35 52 58 0 5ml
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 5
GeM-Bidding-8479681.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Buyer uploaded ATC document
ATC
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
14 Items Sign in to view GEM price trends Sign in for GEM prices
PERTUZUMAB VIAL OF 420 MG INJ
PERTUZUMAB VIAL OF 420 MG INJ
Alectinib 150 mg Tab
Alectinib 150 mg Tab
5 Fluorouracil 500mg 10 ml Inj
5 Fluorouracil 500mg 10 ml Inj
TRANS DERMA PATCH BUPRENORPHINE EP 20 MG
TRANS DERMA PATCH BUPRENORPHINE EP 20 MG
AFATINIB 40 MG TAB
AFATINIB 40 MG TAB
DOXORUBICIN HCL 2MG ML 5ML INJ
DOXORUBICIN HCL 2MG ML 5ML INJ
EPIRUBICIN HCL 10 MG INJ
EPIRUBICIN HCL 10 MG INJ
EXEMESTANE 25 MG TAB
EXEMESTANE 25 MG TAB
FENTANYL 25 MCG TRANSDERMAL
FENTANYL 25 MCG TRANSDERMAL
PACLITAXEL 100MG INJ
PACLITAXEL 100MG INJ
Lenvatinib 4 mg Tab Cap
Lenvatinib 4 mg Tab Cap
ERLOTINIB 150 MG TAB
ERLOTINIB 150 MG TAB
Trastuzumab Deruxtecan concentrate solution for infusion 100mg 5ml Vial Inj
Trastuzumab Deruxtecan concentrate solution for infusion 100mg 5ml Vial Inj
Human papiloma 9 Valent recombinant Vaccine Type 6 11 16 18 31 33 35 52 58 0 5ml
Human papiloma 9 Valent recombinant Vaccine Type 6 11 16 18 31 33 35 52 58 0 5ml
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | PERTUZUMAB VIAL OF 420 MG INJ | PERTUZUMAB VIAL OF 420 MG INJ | 30 | vial | [email protected] | 45 | |
| 2 | Alectinib 150 mg Tab | Alectinib 150 mg Tab | 9 | box of 224 caps | [email protected] | 45 | |
| 3 | 5 Fluorouracil 500mg 10 ml Inj | 5 Fluorouracil 500mg 10 ml Inj | 960 | amp vial | [email protected] | 45 | |
| 4 | TRANS DERMA PATCH BUPRENORPHINE EP 20 MG | TRANS DERMA PATCH BUPRENORPHINE EP 20 MG | 360 | no | [email protected] | 45 | |
| 5 | AFATINIB 40 MG TAB | AFATINIB 40 MG TAB | 690 | no | [email protected] | 45 | |
| 6 | DOXORUBICIN HCL 2MG ML 5ML INJ | DOXORUBICIN HCL 2MG ML 5ML INJ | 240 | amp vial | [email protected] | 45 | |
| 7 | EPIRUBICIN HCL 10 MG INJ | EPIRUBICIN HCL 10 MG INJ | 240 | amp vial | [email protected] | 45 | |
| 8 | EXEMESTANE 25 MG TAB | EXEMESTANE 25 MG TAB | 3,000 | no | [email protected] | 45 | |
| 9 | FENTANYL 25 MCG TRANSDERMAL | FENTANYL 25 MCG TRANSDERMAL | 600 | pack of 1 | [email protected] | 45 | |
| 10 | PACLITAXEL 100MG INJ | PACLITAXEL 100MG INJ | 240 | amp vial | [email protected] | 45 | |
| 11 | Lenvatinib 4 mg Tab Cap | Lenvatinib 4 mg Tab Cap | 1,200 | no | [email protected] | 45 | |
| 12 | ERLOTINIB 150 MG TAB | ERLOTINIB 150 MG TAB | 900 | no | [email protected] | 45 | |
| 13 | Trastuzumab Deruxtecan concentrate solution for infusion 100mg 5ml Vial Inj | Trastuzumab Deruxtecan concentrate solution for infusion 100mg 5ml Vial Inj | 18 | vial | [email protected] | 45 | |
| 14 | Human papiloma 9 Valent recombinant Vaccine Type 6 11 16 18 31 33 35 52 58 0 5ml | Human papiloma 9 Valent recombinant Vaccine Type 6 11 16 18 31 33 35 52 58 0 5ml | 400 | pfs vial | [email protected] | 45 |
Required Documents
Copy of PAN Card
Copy of GSTIN
Copy of Cancelled Cheque
Copy of EFT Mandate certified by the bank
Data Sheet of the products offered
Manufacturer Authorization Certificate
Copies of relevant contracts for experience criteria
Corrigendum Updates
1 Update Update
Extended Deadline
31-Oct-2025, 1:00 pm
Opening Date
31-Oct-2025, 1:30 pm
Reverse Auction Schedule
Start
12-Dec-2025, 1:00 pm
End
13-Dec-2025, 5:52 pm
Duration: 29 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 30-10-2025 15:13:55 | |
| 2 | ********** Under PMA | - | 27-10-2025 12:42:26 | |
| 3 | ********** Under PMA | - | 30-10-2025 15:46:08 | |
| 4 | ********** Under PMA | - | 31-10-2025 11:45:35 | |
| 5 | ********** Under PMA | - | 25-10-2025 17:42:51 | |
| 6 | ********** Under PMA | - | 27-10-2025 12:24:12 | |
| 7 | ********** Under PMA | - | 27-10-2025 12:37:34 | |
| 8 | ********** Under PMA | - | 24-10-2025 16:27:12 | |
| 9 | ********** Under PMA | - | 25-10-2025 17:27:05 | |
| 10 | ********** Under PMA | - | 26-10-2025 16:00:28 | |
| 11 | ********** Under PMA | - | 29-10-2025 17:18:55 | |
| 12 | ********** Under PMA | - | 27-10-2025 12:17:05 | |
| 13 | ********** Under PMA | - | 24-10-2025 19:04:08 | |
| 14 | ********** Under PMA | - | 25-10-2025 18:23:10 | |
| 15 | ********** Under PMA | - | 27-10-2025 12:29:38 | |
| 16 | ********** Under PMA | - | 26-10-2025 13:03:33 |
Frequently Asked Questions
Key insights about MAHARASHTRA tender market
What are the eligibility criteria for Indian Army pharmaceuticals tender in Pune?
Bidders must have at least 3 years of experience supplying similar products to government organizations. Additionally, products must have a minimum of 5 years residual market life and comply with all specified documentation requirements.
What documents are required for Indian Army pharmaceuticals tender submission?
Bidders must submit a PAN Card, GSTIN, Cancelled Cheque, EFT Mandate, and a Data Sheet for each product offered. Manufacturer authorization is also required for authorized distributors.
What are the technical specifications for the pharmaceuticals tender in Pune?
Products must have a minimum of 5 years residual market life. Bidders must provide a Data Sheet for verification, and comply with safety regulations for hazardous materials.
What is the estimated value of the Indian Army pharmaceuticals tender?
The estimated value of the Indian Army pharmaceuticals tender is ₹9,887,067.60. Bidders should ensure competitive pricing while adhering to all specifications and requirements.
How to participate in the Indian Army pharmaceuticals bid in Pune?
To participate, bidders must prepare the required documents including PAN Card, GSTIN, and a Data Sheet for each product. Ensure compliance with eligibility criteria and submit bids through the GeM portal.
What are the payment terms for the Indian Army pharmaceuticals supply contract?
While specific payment terms are not detailed, sellers must upload scanned copies of GST invoices on the GeM portal, confirming payment of GST as part of the invoicing process.
When is the deadline for the Indian Army pharmaceuticals tender in Pune?
The tender submission deadline is not specified in the provided information. Bidders should check the GeM portal for updates on submission timelines.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 5
GeM-Bidding-8479681.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Buyer uploaded ATC document
ATC
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS